Cleared Traditional

K801456 - F/LS MCA APPLICATION SOFTWARE

K801456 is the FDA 510(k) clearance for F/LS MCA APPLICATION SOFTWARE by Instrumentation Laboratory CO. It is a Class 2 Immunology device (product code CFR) cleared through the Traditional 510(k) pathway after a 101-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1980
Decision
101d
Days
Class 2
Risk

K801456 is an FDA 510(k) clearance for the F/LS MCA APPLICATION SOFTWARE. Classified as Hexokinase, Glucose (product code CFR), Class II - Special Controls.

Submitted by Instrumentation Laboratory CO (Mchenry, US). The FDA issued a Cleared decision on October 3, 1980 after a review of 101 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1345 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Instrumentation Laboratory CO devices

Submission Details

510(k) Number K801456 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 24, 1980
Decision Date October 03, 1980
Days to Decision 101 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d faster than avg
Panel avg: 104d · This submission: 101d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CFR Hexokinase, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CFR Hexokinase, Glucose

All 96
Devices cleared under the same product code (CFR) and FDA review panel - the closest regulatory comparables to K801456.
ULTRA CHEM E-GLU #64976 & 65040
K812595 · Harleco · Sep 1981
GLUCOSE-HK SYSTEM PACK TEST
K812303 · Boehringer Mannheim Corp. · Sep 1981
HEXOKINASE, GLUCOSE
K802810 · Beckman Instruments, Inc. · Dec 1980
GLUCOSE REAGENT(UV-HEXOKINASE)
K801765 · Reagents Applications, Inc. · Sep 1980
DATA-ZYME GLUCOSE HEXOKINASE COLOZIMETRI
K801051 · Data Medical Associates, Inc. · May 1980
DATA-ZYME GLUCOSE HEXOKINASE UV
K801052 · Data Medical Associates, Inc. · May 1980